ESN-D(Enveda Therapeutics)

N/A

Report date: 2024/12/03 15:47:25
NME

Base Information

Drug NameESN-D(Enveda Therapeutics)
Drug Alias NameESN-D(Enveda Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG-protein coupled bile acid receptor 1 agonists
TargetsG-protein coupled bile acid receptor 1
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEnveda Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEnveda Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A